This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Jun;43(3):e124-e127.

doi: 10.1111/ijlh.13413. Epub 2020 Nov 30.

Do congenital bleeding disorders have a protective effect against COVID-19? A prospective study

Affiliations

Affiliations

¹ Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Iranian Comprehensive Hemophilia Care Center, Blood And Viral Research Center, Tehran, Iran.
³ Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
⁴ Department of Anesthesia and Anesthesia Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁵ Department of Hematology, Faculty of Paramedicine, AJA University of Medical Sciences, Tehran, Iran.
⁶ Department of Medical Laboratory, Faculty of Paramedical Sciences, Babol University of Medical Sciences, Babol, Iran.
⁷ Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

PMID: 33252816
PMCID: PMC7753473
DOI: 10.1111/ijlh.13413

Do congenital bleeding disorders have a protective effect against COVID-19? A prospective study

Akbar Dorgalaleh et al. Int J Lab Hematol. 2021 Jun.

. 2021 Jun;43(3):e124-e127.

doi: 10.1111/ijlh.13413. Epub 2020 Nov 30.

Authors

Affiliations

¹ Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Iranian Comprehensive Hemophilia Care Center, Blood And Viral Research Center, Tehran, Iran.
³ Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
⁴ Department of Anesthesia and Anesthesia Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁵ Department of Hematology, Faculty of Paramedicine, AJA University of Medical Sciences, Tehran, Iran.
⁶ Department of Medical Laboratory, Faculty of Paramedical Sciences, Babol University of Medical Sciences, Babol, Iran.
⁷ Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

PMID: 33252816
PMCID: PMC7753473
DOI: 10.1111/ijlh.13413

No abstract available

Keywords: COVID-19; SARS-CoV-2; congenital bleeding disorders; hypercoagulability; hypocoagulability.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests.

Similar articles

Congenital Bleeding Disorders and COVID-19 - An Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19.
Dorgalaleh A, Narouei F, Asadi M, Khamsi HM, Gholami MS. Dorgalaleh A, et al. Cardiovasc Hematol Disord Drug Targets. 2022;22(2):83-86. doi: 10.2174/1871529X22666220614090005. Cardiovasc Hematol Disord Drug Targets. 2022. PMID: 35702769
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study.
Coluccia A, Marchesini E, Giuffrida AC, Rivolta GF, Ricca I, Zanon E, Luciani M, De Cristofaro R, Coppola A, Rocino A; AICE MECCOVID-19 Study Group. Coluccia A, et al. Haemophilia. 2021 Jul;27(4):e575-e578. doi: 10.1111/hae.14331. Epub 2021 May 13. Haemophilia. 2021. PMID: 33982839 Free PMC article. No abstract available.
Prevalence of thrombotic complications in children with SARS-CoV-2.
Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A, Soriano-Arandes A, Pareja M, Otheo E, Moraleda C, Tagarro A, Calvo C; EPICO-AEP Working Group. Aguilera-Alonso D, et al. Arch Dis Child. 2021 Nov;106(11):1129-1132. doi: 10.1136/archdischild-2020-321351. Epub 2021 Apr 30. Arch Dis Child. 2021. PMID: 33931403
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy.
Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R. Atar D, et al. Eur Heart J Cardiovasc Pharmacother. 2025 May 2;11(3):275-289. doi: 10.1093/ehjcvp/pvaf006. Eur Heart J Cardiovasc Pharmacother. 2025. PMID: 40145128 Free PMC article. Review.
Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.
Lippi G, Favaloro EJ, Franchini M. Lippi G, et al. J Thromb Thrombolysis. 2012 Oct;34(3):360-6. doi: 10.1007/s11239-012-0753-3. J Thromb Thrombolysis. 2012. PMID: 22644722 Review.

See all similar articles

References

1. Center for Systems Science and Engineering ( CSSE ) at Johns Hopkins University. ( JHU ) . Coronavirus COVID‐19 global cases. Available at www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e...
1. Jordan Rachel E, Peymane A, Cheng KK. Covid‐19: risk factors for severe disease and death. BMJ. 2020;368:m1198. - PubMed
1. Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID‐19 and venous thromboembolism: a meta‐analysis of literature studies. Semin Thromb Hemost. 2020;46(7):763‐771. - PMC - PubMed
1. Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID‐19. Ann Intern Med. 2020;173(4):268‐277. - PMC - PubMed
1. Tuinenburg A, Mauser‐Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with hemophilia. J Thromb Haemost. 2009;7:247‐254. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal